Johnson & Johnson - Research and Development

Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Research-and-Development" stands at 15.71 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 09/30/2024.

Johnson & Johnson's third quarter result of 3.67 Billion USD for the item "Research and Development" represents an increase of 4.44 percent compared to it's second quarter result.

Also, Johnson & Johnson's third quarter result of 3.67 Billion USD for the item "Research and Development" represents a decrease of -25.85 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Johnson & Johnson's third quarter result of 15.71 Billion USD for the item "Research and Development" represents a decrease of -7.53 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -4.28 percent compared to the value the year prior.
The 1 year change in percent is -4.28.
The 3 year change in percent is -2.37.
The 5 year change in percent is 38.31.
The 10 year change in percent is 78.19.

The Serie's long term average value is 11.45 Billion United States Dollars. It's latest available value, on 09/30/2025, is 37.18 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2012, to it's latest available value, on 09/30/2025, is +114.08%.
The Serie's change in percent from it's maximum value, on 12/31/2024, to it's latest available value, on 09/30/2025, is -8.83%.